4-Bromo-2-(methoxymethyl)pyridine, 98%, 5g

Ethyl 6-chloroimidazo[1,2-a]pyridine-3-carboxylate, 95.0%, 10g

4-Amino-6-chloropyridazin-3(2H)-one, 97%, 10g

N-(3-methoxybenzyl)aniline, 95%, 500mg

(3-((2-(Piperidin-1-yl)ethyl)carbamoyl)phenyl)boronic acid, 95.0%, 5g

1-Bromo-4-chlorobutane, 99.00%, 100g

Storage box, PP, L 185 x W 140 x H 80 mm 1 pc

5-chloro-3-{[(3-fluorophenyl)methyl]sulfanyl}-1,2,4-thiadiazole, 95.0%, 1g

(2E)-1-(4-bromophenyl)-3-(2,3,4-trimethoxyphenyl)prop-2-en-1-one, 95.0%, 2g

2-(2,4-Difluoro-phenoxy)-5-nitro-pyridine, 95.0%, 250mg

GC capillary column ROTI®Cap-5 HT, 15 m, 0.25 mm, 0.10 µm, 1 Piece(s)

(3R,6R)-3,6-Dimethyl-1,4-dioxane-2,5-dione, 95.0%, 1g

ethyl 8-(3,4-dimethoxyphenyl)-8-oxooctanoate, 97.0%, 2g